Who owns Eledon Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ELDN from SEC Form 13F filings across 160 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 160 institutions disclosed 46.9M shares of Eledon Pharmaceuticals, Inc. worth $184.6M — about 41.3% of shares outstanding; the largest disclosed holder is BVF INC/IL. Source: SEC Form 13F filings, parsed by EvidInvest.
160
13F holders
$184.6M
value, 2026 filers
41.3%
of shares outstanding (46.9M sh)
50
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ELDN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BVF INC/IL | 6.3M | $24.8M | 0.6% | 5.5% | 0.0% |
| 2 | BlackRock, Inc. | 5.1M | $20.2M | 0.0% | 4.5% | +16.9% |
| 3 | Defilade Capital Management, L.P. | 3.5M | $13.9M | 1.9% | 3.1% | -1.1% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.4M | $13.5M | 0.0% | 3% | +3.8% |
| 5 | GOLDMAN SACHS GROUP INC | 2.5M | $9.9M | 0.0% | 2.2% | +578.3% |
| 6 | Ensign Peak Advisors, Inc | 2.1M | $8.3M | 0.0% | 1.8% | -14.8% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.0M | $7.7M | 0.0% | 1.7% | +9.2% |
| 8 | Catalio Capital Management, LP | 1.7M | $6.7M | 1.3% | 1.5% | +3.4% |
| 9 | STATE STREET CORP | 1.6M | $6.4M | 0.0% | 1.4% | +40.5% |
| 10 | Zimmer Partners, LP | 1.6M | $6.3M | 0.1% | 1.4% | -14.8% |
| 11 | SPHERA FUNDS MANAGEMENT LTD. | 1.2M | $4.7M | 0.6% | 1% | -32.8% |
| 12 | AWM Investment Company, Inc. | 1.1M | $4.3M | 0.4% | 1% | 0.0% |
| 13 | UBS Group AG | 1.0M | $4.1M | 0.0% | 0.9% | +91.5% |
| 14 | KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.0M | $4.1M | 0.4% | 0.9% | 0.0% |
| 15 | MILLENNIUM MANAGEMENT LLCNEW | 979,712 | $3.9M | 0.0% | 0.9% | new |
| 16 | BANK OF AMERICA CORP /DE/ | 883,097 | $3.5M | 0.0% | 0.8% | +1.6% |
| 17 | ADAR1 Capital Management, LLC | 647,812 | $2.6M | 0.1% | 0.6% | -33.5% |
| 18 | 22NW, LP | 636,364 | $2.5M | 2.4% | 0.6% | 0.0% |
| 19 | NORTHERN TRUST CORP | 616,399 | $2.4M | 0.0% | 0.5% | +13.3% |
| 20 | AQR CAPITAL MANAGEMENT LLC | 581,028 | $2.3M | 0.0% | 0.5% | +237.0% |
| 21 | CM Management, LLC | 575,000 | $2.3M | 1.4% | 0.5% | -11.5% |
| 22 | Blue Owl Capital Holdings LP | 566,509 | $2.2M | 0.3% | 0.5% | -60.1% |
| 23 | DIMENSIONAL FUND ADVISORS LP | 538,738 | $2.1M | 0.0% | 0.5% | +703.1% |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLC | 533,365 | $2.1M | 0.0% | 0.5% | +24.1% |
| 25 | VANGUARD FIDUCIARY TRUST CO | 528,963 | $2.1M | 0.0% | 0.5% | +5.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.